Search for Clinical Trial Results

Sponsored By

Cataplexy - 24 Studies Found

Status Study
Recruiting Study Name: A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy
Condition: Narcolepsy With Cataplexy
Date: 2017-01-23
Interventions:
  • Drug: JZP-258
  • Other: Placebo
Recruiting Study Name: Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label Period
Condition:
  • Narcolepsy With Cataplexy
  • Narcolepsy Without
  • Drug: pitolisant Tablet

Completed Study Name: Pitolisant to Assess Weekly Frequency of Cataplexy Attacks and EDS in Narcoleptic Patients (HARMONY CTP)
Condition:
  • Narcolepsy With Cataplexy
  • Excessive Daytime Sleepiness
    • Date: 2013-02-13
    Interventions:
    • Drug: Pitolisant 1 capsule in

Completed Study Name: Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes
Condition: Narcolepsy With Cataplexy
Date: 2006-06-28
Interventions: Drug: Sodium Oxybate (Xyrem) Active Substance: Sodium Oxybate Pharmaceutical form: Oral Solution Concent
Active, not recruiting Study Name: A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy
Condition: Narcolepsy With Cataplexy
Date: 2014-07-28
Interventions: Drug: Xyrem
Completed Study Name: Efficacy and Safety Study of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With Narcolespy
Condition:
  • Narcolepsy
  • Cataplexy
  • Excessiv
    Date: 2010-02-09
    Interventions:
    • Drug: BF2.649 BF2.649 oral cap
Recruiting Study Name: Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy
Condition:
  • Excessive Daytime Sleepiness
  • Cataplexy
  • Drug: Sodium Oxybate
  • Drug: Placebo
Recruiting Study Name: Xyrem and Brain Dopamine in Narcolepsy
Condition: Narcolepsy With Cataplexy
Date: 2015-12-17
Interventions: Drug: Xyrem single 3.0 gram dose Other Names:
Completed Study Name: Single-dose Safety Study of APD916 in Healthy Volunteers
Condition: Narcolepsy With or Without Cataplexy
Date: 2010-03-24
Interventions: Drug: APD916
Completed Study Name: Long Term Open Label Study in Narcolepsy With BF2.649 (Pitolisant)
Condition:
  • Narcolepsy
  • Cataplexy

Date: 2011-06-21
Interventions: Drug: BF2.649 5,10,20,or 40 mg per day, in a once daily scheme
Next >>>